HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement.

Abstract
The restriction fragment length polymorphisms (RFLP) of the X-chromosome phosphoglycerate kinase (PGK) and hypoxanthine phosphoribosyltransferase (HPRT) genes were used to study the clonal basis of the chronic myeloproliferative disorders (CMPD). Analyses were performed on granulocyte and T-lymphocyte fractions obtained from 24 females; 13 had essential thrombocythaemia (ET), eight polycythaemia vera (PV) and three myelofibrosis with myeloid metaplasia (MMM). All 24 of these patients had monoclonal patterns of X-inactivation in the granulocyte fraction. For the T-lymphocyte fraction, non-clonal patterns of X-inactivation were observed in 8/13 patients with ET, 7/8 with PV and 1/3 with MMM, while the remaining eight subjects were found to have monoclonal patterns of X-inactivation. Our findings suggest that the majority of the CMPD in these patients originated from a relatively committed progenitor cell without the capacity to differentiate into T cells, and convincingly demonstrated heterogeneity of lineage involvement.
AuthorsN Tsukamoto, K Morita, T Maehara, K Okamoto, H Sakai, M Karasawa, T Naruse, M Omine
JournalBritish journal of haematology (Br J Haematol) Vol. 86 Issue 2 Pg. 253-8 (Feb 1994) ISSN: 0007-1048 [Print] England
PMID7911034 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hypoxanthine Phosphoribosyltransferase
  • Phosphoglycerate Kinase
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Clone Cells (pathology)
  • Dosage Compensation, Genetic
  • Female
  • Genetic Linkage
  • Granulocytes (pathology)
  • Humans
  • Hypoxanthine Phosphoribosyltransferase (genetics)
  • Middle Aged
  • Myeloproliferative Disorders (genetics)
  • Phosphoglycerate Kinase (genetics)
  • Polycythemia Vera (genetics)
  • Polymorphism, Restriction Fragment Length
  • Primary Myelofibrosis (genetics)
  • T-Lymphocytes (pathology)
  • Thrombocythemia, Essential (genetics)
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: